https://www.selleckchem.com/pr....oducts/nazartinib-eg
-efficacy, anxiety, and HRQoL. The lack of improvement in health-related quality of life (HRQoL) following the SMI may indicate that additional time is required to change behaviors that impact this variable for patients with epilepsy. Additional research should focus on variables associated with medication compliance, epilepsy knowledge, medicine symptom distress, self-efficacy, anxiety, and HRQoL.This study investigated to which degree levetiracetam (LEV) and perampanel (PER), antiseizure medications (ASM) that are bo
Like
Comment
Share
